NCT06698289Completed
Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients
Prevalence of Preoperative Sarcopenia and Its Impact on Surgical Outcomes in Patients With Colorectal Cancer: A Prospective Study
Source: ClinicalTrials.gov · Last updated 25 Mar 2026
Brief summary (registry, in English)
Colorectal cancer is the third most common malignant neoplasm worldwide and the fourth leading cause of cancer-related deaths. Muscle mass loss in oncology patients is most often the result of cancer-related malnutrition. Sarcopenia is a progressive and generalized skeletal muscle disorder associated with increased likelihood of adverse outcomes such as physical disability, poor quality of life, and death. It is characterized by low muscle strength, low muscle quantity and quality, and low physical performance. Sarcopenia is highly prevalent in older adults and those with chronic diseases, including cancer. In the context of colorectal cancer, preoperative sarcopenia has been linked to increased postoperative complications, longer hospital stays, and reduced survival. The aim of this prospective observational study is to evaluate the prevalence of preoperative sarcopenia and postoperative outcomes in patients with colorectal cancer, using validated methods to assess muscle strength, muscle mass, and physical performance.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 70 (actual)
- First submitted
- 18 Nov 2024
- Start date
- 24 Nov 2024
- Primary completion date
- 9 Aug 2025
- Lead sponsor
- Mersin University
- Diseases
- Colorectal cancer
- NCT number
- NCT06698289
What you commit to
- Study type: Observational
- Participants enrolled: 70
- From 24 Nov 2024 to the primary completion date, 9 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years of age
Other
- Patients whose descriptive and clinical characteristics are not recorded in the file records
- Those who did not sign the Informed Volunteer Form/Written Consent Form
Who the study is looking for
- Having a diagnosis of colon cancer
- Having undergone surgery at Mersin University General Surgery Department as of 15.11.2024
- Patients aged 18 years and above
- Patients whose descriptive and clinical characteristics are recorded in their medical files
- Those who have signed the Informed Volunteer Consent Form/Written Consent Form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mersin University Coordinator of this site? Confirm its status | Mersin | Turkey (Türkiye) | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.